Forum for Injection Technique (FIT), India: The Indian recommendations 2.0, for best practice in Insulin Injection Technique, 2015

Indian Journal of Endocrinology and Metabolism

Volumn 19, Issue 3, 2015, Pages 317-329

  Tandon, Nikhil ^a,o   Kalra, Sanjay ^b   Balhara, Yatan Pal Singh ^a   Baruah, Manash P ^c   Chadha, Manoj ^d   Chandalia, Hemraj B ^e   Chowdhury, Subhankar ^f   Jothydev, Kesavadev ^g   Kumar, Prasanna ^h   Madhu, V ⁱ   Mithal, Ambrish ^j   Modi, Sonal ^e   Pitale, Shailesh ^j   Sahay, Rakesh ^k   Shukla, Rishi ^l   Sundaram, Annamalai ^m   Unnikrishnan, Ambika G ⁿ   Wangnoo, Subhash K ^o  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b India   (India)

^c Excel Care Hospitals   (India)

^d P D HINDUJA NATIONAL HOSPITAL   (India)

^e Diabetes Endocrine Nutrition Management and Research Center (DENMARC)   (India)

^f INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^g Jothydev's Diabetes and Reserarch Center   (India)

^h M S RAMAIAH MEDICAL COLLEGE   (India)

ⁱ UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^j Medanta Medicity ^*  (India)

^k OSMANIA GENERAL HOSPITAL   (India)

^l Regency Hospital Ltd   (India)

^m Kilpauk Medical College   (India)

ⁿ CEO and Endocrinologist Chellaram Diabetes Institute   (India)

^o INDRAPRASTHA APOLLO HOSPITAL   (India)

more..

Author keywords

Adherence; aspart; degludec; detemir; diabetes; education; glargine; glucagon like peptide 1 receptor agonists; glulisine; injection sites; injection technique; injections; insulin; insulin analogs; lipohypertrophy; lispro; needle length; skin fold; storage

Indexed keywords

EID: 84981156288     PISSN: 22308210     EISSN: 22309500     Source Type: Journal    
DOI: 10.4103/2230-8210.152762     Document Type: Review

References (63)

1. Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007;125:217-30.
2. The IDF Atlas, December 2014. Available from: http://www.idf. org/sites/default/files/DA-regional-factsheets-2014-FINAL.pdf. [Last accessed on 2014 Dec 15].
3. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14.
4. Crasto W, Jarvis J, Khunti K, Davies MJ. New insulins and new insulin regimens: A review of their role in improving glycaemic control in patients with diabetes. Postgrad Med J 2009;85:257-67.
5. Prasad R. Innovate for diabetes in India. Available from: http://www.blogs. novonordisk.com/graduates/2010/10/27/innovate-for-diabetes-in-India/. [Last accessed on 2014 Dec 15].
6. Funnell MM. Lessons from DAWN: Implementing effective insulin therapy. Int J Adv Nurs Pract 2009;10:2.
7. Strauss K, De Gols H, Hannet I, Partanen TM, Frid A. A pan-European epidemiologic study of insulin injection technique in patients with diabetes. Pract Diabetes Int 2002;19:71-6.
8. New UK recommendations for best practice in diabetes injection technique. Available from: http://www.primarycaretoday.co.uk/training/?pid=4216 and lsid=4268 and edname=29301.htm and ped=29301. [Last accessed on 2014 Dec 15].
9. Kamath SS. IAP workshop on safe injection practices: Recommendations and IAP plan of action. Indian Pediatr 2005;42:155-61.
10. Injectable drug delivery 2011: Device focus. Available from: http://www.ondrugdelivery.com/publications/Injectable%20 Devices%20 2011/Injection%20Devices%20June%202011%20 Med%20Res.pdf. [Last accessed on 2014 Dec 15].
11. Dolinar R. The importance of good insulin injection practices in diabetes management. US Endocrinol 2009;5:49-52.
12. Grassi G, Scuntero P, Trepiccioni R, Marubbi F, Strayss K. Optimizing insulin injection technique and its effect on blood glucose control. Journal of Clinical Translational Endocrinology. 2014;148:145-50.
13. Davidson JA. New injection recommendations for patients with diabetes. Diabetes Metab 2010;36 Suppl 2:S2.
14. Frid A, Hirsch L, Gaspar R, Hicks D, Kreugel G, Liersch J, et al. New injection recommendations for patients with diabetes. Diabetes Metab 2010;36 Suppl 2:S3-18.
15. Okazaki K, Goto M, Yamamoto T, Tsujii S, Ishii H. Barriers and facilitators in relation to starting insulin therapy in type 2 diabetes. Diabetes 1999;48 Suppl 1:A319. [Abstract].
16. Hendra TJ. Starting insulin therapy in elderly patients. J R Soc Med 2002;95:453-5.
17. Korytkowski M, Bell D, Jacobsen C, Suwannasari R; Flex Pen Study Team. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003;25:2836-48.
18. Bohannon NJ, Jack DB. Type II diabetes: Tips for managing your older patients. Geriatrics 1996;51:28-35.
19. Baruah MP. Insulin pens: The modern delivery devices. J Assoc Physicians India 2011;59 Suppl: 38-40.
20. Coscelli C, Lostia S, Lunetta M, Nosari I, Coronel GA. Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract 1995;28:173-7.
21. Baruah MP, Kalra S, Unnikrishnan AG, Raza SA, Somasundaram N, John M, et al. Management of hyperglycemia in geriatric patients with diabetes mellitus: South Asian consensus guidelines. Indian J Endocrinol Metab 2011;15:75-90.
22. American Diabetes Association. Insulin administration. Diabetes Care 2004;27 Suppl 1:S106-9.
23. Travel and diabetes. Available from: http://www.sweet.org.au/docs/professionals/14-Travel-and-Diabetes.pdf. [Last accessed on 2014 Dec 15].
24. Grassi G, Scuntero P, Trepiccioni R, Marubbi F, Strauss K. Insulin syringes. Optimizing insulin injection technique and its effect on blood glucose control. J Clin Trans Endocrinol 2014;148:145-50. Available from: http://www.bd.com/us/diabetes/page. aspx-cat=7001 & id=7251. [Last accessed on 2014 Dec 15].
25. Gitanjali B. A tale of too many strengths: Can we minimize prescribing errors and dispensing errors with so many formulations in the market? J Pharmacol Pharmacother 2011;2:147-9.
26. Holleman F, Vermeijden JW, Kuck EM, Hoekstra JB, Erkelens DW. Compatibility of insulin pens and cartridges. Lancet 1997;350:1601-2.
27. Insulin pens. Available from: http://www.bd.com/us/diabetes/page. aspx-cat=7001 and id=7254. [Last accessed on 2014 Dec 15].
28. Syringe and pen needle sizes. Available from: http://www. bd.com/us/diabetes/page.aspx-cat=7001 & id=7253. [Last accessed on 2014 Dec 15].
29. Skin thickness and needle size. Available from: http://www.bd.com/us/diabetes/page.aspx-cat=7001 & id=32371. [Last accessed on 2014 Dec 15].
30. Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: Implications for needle length recommendations. Curr Med Res Opin 2010;26:1519-30.
31. Lo Presti D, Ingegnosi C, Strauss K. Skin and subcutaneous thickness at injecting sites in children with diabetes: Ultrasound findings and recommendations for giving injection. Pediatr Diabetes 2012;13:525-33.
32. Yadav S, Parakh A. Insulin therapy. Indian Pediatr 2006;43:863-72.
33. Injection site selection. Available from: http://www.bd.com/us/diabetes/page.aspx-cat=7001 and id=7261. [Last accessed on 2014 Dec 15].
34. Down S, Kirkland F. Injection technique in insulin therapy. Nurs Times 2012;108:18, 20-1.
35. Basi M, Hicks D, Kirkland F, Pledger J, Burmiston S. Improving diabetes injection technique. Clin Serv J 2010.
36. Das AK. Rapid acting analogues in diabetes mellitus management. J Assoc Physician India 2009. Available from: http://www.japi.org/february-2009/rapid-acting-analogue.html. [Last accessed on 2014 Dec 15].
37. Deckert T. Intermediate-acting insulin preparations: NPH and lente. Diabetes Care 1980;3:623-6.
38. How to inject an insulin syringe. Available from: http://www.bd.com/us/diabetes/page.aspx-cat=7001 & id=7258. [Last accessed on 2014 Dec 15].
39. Bohannon NJ. Insulin delivery using pen devices. Simple-to-use tools may help young and old alike. Postgrad Med 1999;106:57-8, 61-4, 68.
40. Czupryniak L, Drzewoski J. Insulin injection mean time interval it is NOT its length that matters. Pract Diabetes Int 2001;18:338.
41. Fowler MJ. Diabetes treatment, Part 3: Insulin and incretins. Clin Diabetes 2008;26:35-9.
42. Lantus Product Monograph. Available from: http://www.products. sanofi.ca/en/lantus.pdf. [Last accessed on 2014 Dec 15].
43. Workman B. Safe injection techniques. Nurs Stand 1999;13:47-53.
44. Kalra S, Balhara YP, Baruah MP, Chadha M, Chandalia HB, Chowdhury S, et al.. Addendum 2: Forum for injection technique, India. Indian J Endocrinol Metab 2014;18:800-3.
45. Blanco M, Hernández MT, Strauss KW, Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab 2013;39:445-53.
46. Dische FE, Wernstedt C, Westermark GT, Westermark P, Pepys MB, Rennie JA, et al. Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia 1988;31:158-61.
47. Swift B. Examination of insulin injection sites: An unexpected finding of localized amyloidosis. Diabet Med 2002;19:881-2.
48. Albert SG, Obadiah J, Parseghian SA, Yadira Hurley M, Mooradian AD. Severe insulin resistance associated with subcutaneous amyloid deposition. Diabetes Res Clin Pract 2007;75:374-6.
49. Westermark P, Araki S, Benson MD, Cohen AS, Frangione B, Masters CL, et al. Nomenclature of amyloid fibril proteins. Report from the Meeting of the International Nomenclature Committee on Amyloidosis, August 8-9, 1998. Part 1. Amyloid 1999;6:63-6.
50. Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S, et al. Amyloid fibril protein nomenclature-2002. Amyloid 2002;9:197-200.
51. Shikama Y, Kitazawa J, Yagihashi N, Uehara O, Murata Y, Yajima N, et al. Localized amyloidosis at the site of repeated insulin injection in a diabetic patient. Intern Med 2010;49:397-401.
52. Recommendations on Safe Disposal of Used Needles and Syringes in the Context of Targeted Intervention for Injecting Drug Users. Available from: http://www.nacoonline.org/upload/NGO%20 & %20Targeted/waste%20disposal%20 recommendations%20for%20IDU%20TI.pdf. [Last accessed on 2014 Dec 15].
53. Misnikova IV, Dreval AV, Gubkina VA, Rusanova EV. The risks of repeated use of insulin pen needles in patients with diabetes mellitus. J Diabetol 2011;1:1-5.
54. WISE consensus group. WISE recommendations to ensure the safety of injections in diabetes. Available from: http://www. em-consulte.com/showarticlefile/689682/main.pdf. [Last accessed on 2014 Dec 15].
55. Palios J, Kadoglou NP, Lampropoulos S. The pathophysiology of HIV/HAART-related metabolic syndrome leading to cardiovascular disorders: The emerging role of adipokines. Exp Diabetes Res 2012;2012:103063.
56. Kalra S, Unnikrishnan AG, Raza SA, Bantwal G, Baruah MP, Latt TS, et al. South Asian consensus recommendations for the rational management of diabetes in human immunodeficiency virus/acquired immunodeficiency syndrome. Indian J Endocrinol Metab 2011;15:242-50.
57. Kalra S, Balhara YS, Baruah MP, Chadha M, Chandalia HB, Chowdhury S, et al. Addendum: First injection technique recommendations for patients with diabetes, forum for injection techniques India. Indian J Endocrinol Metab 2013;17:1005-8.
58. Kesavadev J, Das AK, Unnikrishnan R 1st, Joshi SR, Ramachandran A, Shamsudeen J, et al. Use of insulin pumps in India: Suggested guidelines based on experience and cultural differences. Diabetes Technol Ther 2010;12:823-31.
59. Bode BW. Comparison of pharmacokinetic properties, physicochemical stability, and pump compatibility of 3 rapid-acting insulin analogues-aspart, lispro, and glulisine. Endocr Pract 2011;17:271-80.
60. Ponder SW, Skyler JS, Kruger DF, Matheson D, Brown BW. Unexplained hyperglycemia in continuous subcutaneous insulin infusion: Evaluation and treatment. Diabetes Educ 2008;34:327-33.
61. Beran D. Improving access to insulin: What can be done? Diabetes Manage 2011;1:67-76.
62. Kalra S, Kalra B, Batra P. Patient motivation for insulin/injectable therapy: The Karnal model. Int J Clin Cases Invest 2010;1:11-5.
63. Kalra S, Kalra B. A good diabetes counselor 'Cares': Soft skills in diabetes counseling. Int J Health 2010;11:1-3.